Grant: Discovery Grants Program - Individual
University of Guelph
$50,000.00
Human enzymes of xenobiotic metabolism
EF 2011-12
Résumé
Human enzymes of xenobiotic metabolism
) Xenobiotics are foreign chemicals such as drugs, carcinogens, and pollutants. Foreign compounds are metabolized in the human body in chemically remarkable ways. These metabolic processes, catalyzed by enzymes such as cytochrome P450 and glutathione transferase, can be crucial in determining the toxic effects of chemicals. Therefore, they are of great interest not only in biochemistry but also in the allied disciplines of pharmacology and toxicology. The central theme of Dr. Josephy's research is understanding the biochemistry of the enzymes that catalyze the metabolism of xenobiotics, with particular attention to their protein structures and catalytic functions. His lab. has brought together two different biotechnologies: bacterial mutagenicity assays and recombinant protein expression. In the new assay systems developed in Dr. Josephy's lab., E. coli bacteria are used to detect chemical mutagens, and they are also ""taught"" to metabolize foreign chemicals in the same ways that humans do. That is, human enzymes are expressed as recombinant proteins within the bacterial cells. This approach has led to increasingly reliable and relevant assays for toxic chemicals, and it also provides insight into the mechanisms of action of important human enzymes. The functional effects of naturally occurring variations in these human genes/enzymes, which are being discovered via genome sequencing projects, are now being studied. Another avenue of research is the ""evolution"", in the laboratory, of enzymes with altered sequences and catalytic activities. This aspect of the research program is pursued by randomly mutagenizing the gene encoding the enzyme, and then using the mutagenicity assay to screen libraries of mutants and identify ones with altered activities.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Ontario, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
2537-2007
Name nom
Josephy, David
Department département
Molecular and Cellular Biology
Organization id
24
Institution établissement
University of Guelph
Province en
Ontario
Province fr
Ontario
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2011
Competition year année de concours
2007
Award amount
50000
Program id
RGPIN
Program nane en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
Discovery grants programs
Group fr
Programmes de subventions à la découverte
Committee code
32
Committee name en
Cell Biology
Committee name fr
Biologie cellulaire
Area of application code
1101
Area of application group en
Health, education and social services
Area of application group fr
Santé publique, éducation et services sociaux
Area of application en
Human health (including medically-related psychological research)
Area of application fr
Santé publique (y compris recherche psychologique liée à la médecine)
Research subject code
5404
Research subject group en
Biochemistry
Research subject group fr
Biochimie
Research subject en
Enzymes
Research subject fr
Enzymes
Partie
5
Nb partie
5
Application title
Human enzymes of xenobiotic metabolism
Keyword
NSERC
Application summary
Human enzymes of xenobiotic metabolism
) Xenobiotics are foreign chemicals such as drugs, carcinogens, and pollutants. Foreign compounds are metabolized in the human body in chemically remarkable ways. These metabolic processes, catalyzed by enzymes such as cytochrome P450 and glutathione transferase, can be crucial in determining the toxic effects of chemicals. Therefore, they are of great interest not only in biochemistry but also in the allied disciplines of pharmacology and toxicology. The central theme of Dr. Josephy's research is understanding the biochemistry of the enzymes that catalyze the metabolism of xenobiotics, with particular attention to their protein structures and catalytic functions. His lab. has brought together two different biotechnologies: bacterial mutagenicity assays and recombinant protein expression. In the new assay systems developed in Dr. Josephy's lab., E. coli bacteria are used to detect chemical mutagens, and they are also ""taught"" to metabolize foreign chemicals in the same ways that humans do. That is, human enzymes are expressed as recombinant proteins within the bacterial cells. This approach has led to increasingly reliable and relevant assays for toxic chemicals, and it also provides insight into the mechanisms of action of important human enzymes. The functional effects of naturally occurring variations in these human genes/enzymes, which are being discovered via genome sequencing projects, are now being studied. Another avenue of research is the ""evolution"", in the laboratory, of enzymes with altered sequences and catalytic activities. This aspect of the research program is pursued by randomly mutagenizing the gene encoding the enzyme, and then using the mutagenicity assay to screen libraries of mutants and identify ones with altered activities.